Psyence Group Inc C.PSYG

Alternate Symbol(s): PSYGF

Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, cultivation, and production of psilocybin mushrooms and functional over-the-counter mushroom products. The company offers its functional mushroom products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.

CSE:PSYG - Post by User

Psyence Group Inc

<< Previous

Bullboard Posts

Next >>

(5)
•••

Post by SEEdgaron Jan 31, 2021 1:26pm

476 Views

Post# 32431844

interview

great interview with the CEO and 1 of the co- founders Jody Aufrichtig Psyence has low float and 52% insider owned, Jody came from Canopy Growth Africa and Psyence Facility is the old canopy Growth Africa facility. Federally licensed and operational psilocybin cultivation and processing. Built to BSI standards at secure GAP/GMP production hub. Licensed, operational and established for export, innovation, standardization and growth. In 2019 the Kingdom of Lesotho awarded Psyence Group one of world’s first commercial licenses to import, cultivate, manufacture and export psilocybin mushrooms. https://www.psychedelicfinance.com/articles/jody-aufrichtig-co-founder-president-and-ceo-the-psyence-group

<< Previous

Bullboard Posts

Next >>

The 2026 buildout that turns a resource into a platform